| Year |
Citation |
Score |
| 2023 |
Steiner ST, Maisuls I, Junker A, Fritz G, Faust A, Strassert CA. Concerning the photophysics of fluorophores towards tailored bioimaging compounds: a case study involving S100A9 inflammation markers. Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society For Photobiology. PMID 37303026 DOI: 10.1007/s43630-023-00432-2 |
0.716 |
|
| 2023 |
Siutkina AI, Kalinina S, Liu R, Heitman LH, Junker A, Daniliuc CG, Kalinin DV. Microwave-Assisted Synthesis, Structure, and Preliminary Biological Evaluation of Novel 6-Methoxy-5,6-dihydro-5-azapurines. Acs Omega. 8: 14097-14112. PMID 37091407 DOI: 10.1021/acsomega.3c00765 |
0.745 |
|
| 2023 |
Patberg M, Oniani T, Disse P, Peischard S, Vinnenberg L, Zobeiri M, Romanelli MN, Epping L, Wiendl H, Meuth SG, Hundehege P, Seebohm G, Budde T, Junker A. Optimized synthesis and pharmacological evaluation of HCN channel inhibitor EC18. Archiv Der Pharmazie. e2200665. PMID 36949271 DOI: 10.1002/ardp.202200665 |
0.712 |
|
| 2023 |
Schmidt S, Isaak A, Junker A. Spotlight on P2X7 Receptor PET Imaging: A Bright Target or a Failing Star? International Journal of Molecular Sciences. 24. PMID 36674884 DOI: 10.3390/ijms24021374 |
0.725 |
|
| 2023 |
Turgutalp B, Bhattarai P, Ercetin T, Luise C, Reis R, Gurdal EE, Isaak A, Biriken D, Dinter E, Sipahi H, Schepmann D, Junker A, Wünsch B, Sippl W, Gulcan HO, et al. Correction to "Discovery of Potent Cholinesterase Inhibition-Based Multi-Target-Directed Lead Compounds for Synaptoprotection in Alzheimer's Disease". Journal of Medicinal Chemistry. 66: 1652. PMID 36651752 DOI: 10.1021/acs.jmedchem.2c02094 |
0.722 |
|
| 2022 |
Turgutalp B, Bhattarai P, Ercetin T, Luise C, Reis R, Gurdal EE, Isaak A, Biriken D, Dinter E, Sipahi H, Schepmann D, Junker A, Wünsch B, Sippl W, Gulcan HO, et al. Discovery of Potent Cholinesterase Inhibition-Based Multi-Target-Directed Lead Compounds for Synaptoprotection in Alzheimer's Disease. Journal of Medicinal Chemistry. PMID 36084304 DOI: 10.1021/acs.jmedchem.2c01003 |
0.736 |
|
| 2022 |
Isaak A, Dobelmann C, Füsser FT, Erlitz KS, Koch O, Junker A. Unveiling the Structure-Activity Relationships at the Orthosteric Binding Site of P2X Ion Channels: The Route to Selectivity. Journal of Medicinal Chemistry. PMID 35930402 DOI: 10.1021/acs.jmedchem.2c00812 |
0.757 |
|
| 2022 |
Oniani T, Vinnenberg L, Chaudhary R, Schreiber JA, Riske K, Williams B, Pape HC, White JA, Junker A, Seebohm G, Meuth SG, Hundehege P, Budde T, Zobeiri M. Effects of Axonal Demyelination, Inflammatory Cytokines and Divalent Cation Chelators on Thalamic HCN Channels and Oscillatory Bursting. International Journal of Molecular Sciences. 23. PMID 35682964 DOI: 10.3390/ijms23116285 |
0.68 |
|
| 2022 |
Lemmerhirt JP, Isaak A, Liu R, Kock M, Daniliuc CG, Jacobson KA, Heitman LH, Junker A. Development of Bicyclo[3.1.0]hexane-Based A Receptor Ligands: Closing the Gaps in the Structure-Affinity Relationships. Molecules (Basel, Switzerland). 27. PMID 35408685 DOI: 10.3390/molecules27072283 |
0.788 |
|
| 2022 |
Scortichini M, Idris RM, Moschütz S, Keim A, Salmaso V, Dobelmann C, Oliva P, Losenkova K, Irjala H, Vaittinen S, Sandholm J, Yegutkin GG, Sträter N, Junker A, Müller CE, et al. Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 Inhibitors. Journal of Medicinal Chemistry. PMID 35080883 DOI: 10.1021/acs.jmedchem.1c01852 |
0.74 |
|
| 2021 |
Patberg M, Isaak A, Füsser F, Ortiz Zacarías NV, Vinnenberg L, Schulte J, Michetti L, Grey L, van der Horst C, Hundehege P, Koch O, Heitman LH, Budde T, Junker A. Piperazine squaric acid diamides, a novel class of allosteric P2X7 receptor antagonists. European Journal of Medicinal Chemistry. 226: 113838. PMID 34571173 DOI: 10.1016/j.ejmech.2021.113838 |
0.755 |
|
| 2021 |
Silva DG, Feijens PB, Hendrickx R, Matheeussen A, Grey L, Caljon G, Maes L, Emery FS, Junker A. Development of Novel Isoindolone-Based Compounds against Trypanosoma brucei rhodesiense. Chemistryopen. 10: 922-927. PMID 34553828 DOI: 10.1002/open.202100180 |
0.734 |
|
| 2021 |
Oliva P, Scortichini M, Dobelmann C, Jain S, Gopinatth V, Toti KS, Phung NB, Junker A, Jacobson KA. Structure-Activity Relationships of Pyrimidine Nucleotides Containing a 5'-α,β-Methylene Diphosphonate at the P2Y Receptor. Bioorganic & Medicinal Chemistry Letters. 128137. PMID 34048882 DOI: 10.1016/j.bmcl.2021.128137 |
0.763 |
|
| 2020 |
Wagner S, de Moura Gatti F, Silva DG, Ortiz Zacarias NV, Zweemer AJM, Hermann S, De Maria M, Koch M, Weiss C, Schepmann D, Heitman LH, Tschammer N, Kopka K, Junker A. Development of the First Potential Nonpeptidic Positron Emission Tomography Tracer for the Imaging of CCR2 Receptors. Chemmedchem. PMID 33205603 DOI: 10.1002/cmdc.202000728 |
0.749 |
|
| 2020 |
Silva DG, Junker A, de Melo SMG, Fumagalli F, Gillespie JR, Molasky N, Buckner FS, Matheeussen A, Caljon G, Maes L, Emery FS. Synthesis and structure-activity relationships of imidazopyridine/pyrimidine- and furopyridine-based anti-infective agents against trypanosomiases. Chemmedchem. PMID 33078573 DOI: 10.1002/cmdc.202000616 |
0.738 |
|
| 2019 |
Liu Q, Junker A, Murakami K, Hu P. Automated Counting of Cancer Cells by Ensembling Deep Features. Cells. 8. PMID 31480740 DOI: 10.3390/Cells8091019 |
0.689 |
|
| 2019 |
Junker A, Renn C, Dobelmann C, Namasivayam V, Jain S, Losenkova K, Irjala H, Duca S, Balasubramanian R, Chakraborty S, Börgel F, Zimmermann H, Yegutkin GG, Müller CE, Jacobson KA. Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors. Journal of Medicinal Chemistry. PMID 30895781 DOI: 10.1021/Acs.Jmedchem.9B00164 |
0.751 |
|
| 2017 |
Thum S, Kokornaczyk AK, Seki T, De Maria M, Ortiz Zacarias NV, de Vries H, Weiss C, Koch M, Schepmann D, Kitamura M, Tschammer N, Heitman LH, Junker A, Wünsch B. Synthesis and biological evaluation of chemokine receptor ligands with 2-benzazepine scaffold. European Journal of Medicinal Chemistry. 135: 401-413. PMID 28463783 DOI: 10.1016/J.Ejmech.2017.04.046 |
0.775 |
|
| 2017 |
Kokornaczyk AK, Thum S, Daniliuc CG, Junker A, Wünsch B. Molecular structure of a brominated 2-benzazepinone – a crucial intermediate in the synthesis of novel chemokine CCR2 receptor antagonists Zeitschrift FüR Naturforschung B. 72: 421-424. DOI: 10.1515/Znb-2017-0030 |
0.442 |
|
| 2016 |
Junker A, Balasubramanian R, Ciancetta A, Uliassi E, Kiselev E, Martiriggiano C, Trujillo K, Mtchedlidze G, Birdwell L, Brown KA, Harden TK, Jacobson KA. Structure-Based Design of 3-(4-Aryl-1H-1,2,3-triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists. Journal of Medicinal Chemistry. PMID 27331270 DOI: 10.1021/Acs.Jmedchem.6B00044 |
0.782 |
|
| 2015 |
Strunz AK, Zweemer AJ, Weiss C, Schepmann D, Junker A, Heitman LH, Koch M, Wünsch B. Synthesis and biological evaluation of spirocyclic antagonists of CCR2 (chemokine CC receptor subtype 2). Bioorganic & Medicinal Chemistry. 23: 4034-49. PMID 25766632 DOI: 10.1016/J.Bmc.2015.02.019 |
0.747 |
|
| 2015 |
Junker A, Kokornaczyk AK, Zweemer AJ, Frehland B, Schepmann D, Yamaguchi J, Itami K, Faust A, Hermann S, Wagner S, Schäfers M, Koch M, Weiss C, Heitman LH, Kopka K, et al. Synthesis, binding affinity and structure-activity relationships of novel, selective and dual targeting CCR2 and CCR5 receptor antagonists. Organic & Biomolecular Chemistry. 13: 2407-22. PMID 25566983 DOI: 10.1039/C4Ob02397H |
0.785 |
|
| 2014 |
Junker A, Schepmann D, Yamaguchi J, Itami K, Faust A, Kopka K, Wagner S, Wünsch B. Diverse modifications of the 4-methylphenyl moiety of TAK-779 by late-stage Suzuki-Miyaura cross-coupling. Organic & Biomolecular Chemistry. 12: 177-86. PMID 24217712 DOI: 10.1039/C3Ob41873A |
0.769 |
|
| 2013 |
Junker A, Yamaguchi J, Itami K, Wünsch B. Synthesis of thiophene-based TAK-779 analogues by C-H arylation. The Journal of Organic Chemistry. 78: 5579-86. PMID 23642160 DOI: 10.1021/Jo400692P |
0.724 |
|
| Show low-probability matches. |